<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>43(3)</volume><submitter>Acheampong I</submitter><funding>Universitätsklinikum Düsseldorf. Anstalt öffentlichen Rechts</funding><pubmed_abstract>Impaired T-cell responses to mitogens and high T-cell activation marker (TAM) expression on Mycobacterium tuberculosis-specific T-cells characterize immunopathology in patients with tuberculosis (TB). In a study of patients with TB (n = 60) and asymptomatic contacts (controls, n = 37), we found that TB patients had higher CD38&lt;sup>+&lt;/sup> T-cell proportions specific for M. tuberculosis protein (PPD&lt;sub>Mtb&lt;/sub>), yet total proportions of PPD&lt;sub>Mtb&lt;/sub>-specific T-cells were comparable. Notably, both activated (CD38&lt;sup>+&lt;/sup>) and total IFN-γ&lt;sup>+&lt;/sup> T-cells from TB patients had lower mitogen (phytohemagglutinin, PHA)-induced responses. This impaired mitogen response improved the classification efficacy of the TAM-TB assay, especially employing the PPD/PHA-induced T-cell ratio.</pubmed_abstract><journal>European journal of clinical microbiology &amp; infectious diseases : official publication of the European Society of Clinical Microbiology</journal><pagination>611-616</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10917863</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Differences in PPD- and mitogen-induced T-cell activation marker expression characterize immunopathology in acute tuberculosis patients.</pubmed_title><pmcid>PMC10917863</pmcid><pubmed_authors>Abass MK</pubmed_authors><pubmed_authors>Mayatepek E</pubmed_authors><pubmed_authors>Yeboah A</pubmed_authors><pubmed_authors>Acheampong I</pubmed_authors><pubmed_authors>Jacobsen M</pubmed_authors><pubmed_authors>Lamptey M</pubmed_authors><pubmed_authors>Debrah LB</pubmed_authors><pubmed_authors>Kumbel F</pubmed_authors><pubmed_authors>Phillips RO</pubmed_authors><pubmed_authors>Frimpong M</pubmed_authors><pubmed_authors>Osei-Yeboah F</pubmed_authors><pubmed_authors>Arthur JF</pubmed_authors><pubmed_authors>Debrah A</pubmed_authors><pubmed_authors>Owusu DO</pubmed_authors><pubmed_authors>Seyfarth J</pubmed_authors><pubmed_authors>Aniagyei W</pubmed_authors><pubmed_authors>Laing EF</pubmed_authors><pubmed_authors>Minadzi D</pubmed_authors><pubmed_authors>Adankwah E</pubmed_authors><pubmed_authors>Vivekanandan MM</pubmed_authors><pubmed_authors>Gawusu A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Differences in PPD- and mitogen-induced T-cell activation marker expression characterize immunopathology in acute tuberculosis patients.</name><description>Impaired T-cell responses to mitogens and high T-cell activation marker (TAM) expression on Mycobacterium tuberculosis-specific T-cells characterize immunopathology in patients with tuberculosis (TB). In a study of patients with TB (n = 60) and asymptomatic contacts (controls, n = 37), we found that TB patients had higher CD38&lt;sup>+&lt;/sup> T-cell proportions specific for M. tuberculosis protein (PPD&lt;sub>Mtb&lt;/sub>), yet total proportions of PPD&lt;sub>Mtb&lt;/sub>-specific T-cells were comparable. Notably, both activated (CD38&lt;sup>+&lt;/sup>) and total IFN-γ&lt;sup>+&lt;/sup> T-cells from TB patients had lower mitogen (phytohemagglutinin, PHA)-induced responses. This impaired mitogen response improved the classification efficacy of the TAM-TB assay, especially employing the PPD/PHA-induced T-cell ratio.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2026-06-12T10:08:28.814Z</modification><creation>2026-06-12T03:12:19.116Z</creation></dates><accession>S-EPMC10917863</accession><cross_references><pubmed>38167987</pubmed><doi>10.1007/s10096-023-04741-3</doi></cross_references></HashMap>